Skip to content
HomeLatest newsJohnson & Johnson debuts a groundbreaking R&D facility in the San Francisco Bay Area
Johnson-and-Johnson-Debuts-a-Groundbreaking-R-and-D-Facility-in-the-San-Francisco-Bay-Area-0922.png

Johnson & Johnson debuts a groundbreaking R&D facility in the San Francisco Bay Area

Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.

The new research site, located near the Birthplace of Biotechnology, will be home to scientists focused on finding new solutions for everything from infectious diseases to retinal diseases, using such cutting-edge technologies as gene and RNA therapies and advanced data science.

And thanks to its Bay Area address, the new site will also enable Silicon Valley healthcare entrepreneurs and other researchers to collaborate with company scientists to help advance the next great healthcare breakthroughs.

Watch this drone video for an inside look at the new healthcare innovation hub.

hqdefault.jpg

Check out more innovation in action

Learn how Johnson & Johnson is working to find solutions for some of the world’s toughest health challenges.

More from Johnson & Johnson

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.